A clinical study of MK-8294 in participants with advanced solid tumors (MK-8294-001)

Trial Identifier: 8294-001
Sponsor: MSD
Start Date: July 2025
Primary Completion Date: August 2027
Study Completion Date: August 2027
Condition: Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
Protocol Plain Language Summary

Trial Locations

Country Location
Israel, N/A Haifa, N/A, Israel, 3109601
Israel, N/A Ramat Gan, N/A, Israel, 5265601
Netherlands, Gelderland Nijmegen, Gelderland, Netherlands, 6525 GA
Netherlands, Noord-Holland Amsterdam, Noord-Holland, Netherlands, 1066 CX
United States, IL Chicago, IL, United States, 60611